Questionnaire survey evaluating disease-related knowledge for 149 primary gout patients and 184 doctors in South China

[1]  Charles King,et al.  2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia , 2012, Arthritis care & research.

[2]  F. Perez-Ruiz,et al.  Gout: why is this curable disease so seldom cured? , 2012, Annals of the rheumatic diseases.

[3]  M. Doherty,et al.  Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study , 2012, Annals of the rheumatic diseases.

[4]  Harjinder Singh,et al.  Living With Gout in New Zealand: An Exploratory Study Into People’s Knowledge About the Disease and Its Treatment , 2012, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[5]  M. Doherty,et al.  Patient and provider barriers to effective management of gout in general practice: a qualitative study , 2012, Annals of the rheumatic diseases.

[6]  H. Schumacher,et al.  Development and Evaluation of a Survey of Gout Patients Concerning Their Knowledge About Gout , 2011, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[7]  N. Edwards.  Quality of Care in Patients with Gout: Why is Management Suboptimal and What Can Be Done About It? , 2011, Current rheumatology reports.

[8]  A. Forsythe,et al.  Chronic gout: epidemiology, disease progression, treatment and disease burden , 2010, Current medical research and opinion.

[9]  Zirui Chen,et al.  [Epidemiological study on hyperuricemia and gout in Foshan areas, Guangdong province]. , 2010, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[10]  Sarah Velten,et al.  Patients and providers view gout differently: a qualitative study , 2010, Chronic illness.

[11]  H. Schumacher,et al.  Quality of Life and Disability in Patients with Treatment-Failure Gout , 2009, The Journal of Rheumatology.

[12]  A. Weaver,et al.  How PCP Education Can Impact Gout Management: The Gout Essentials , 2008, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[13]  W. Taylor,et al.  The Health Assessment Questionnaire Disability Index is a valid measure of physical function in gout. , 2008, Clinical and experimental rheumatology.

[14]  T. Mikuls.  Quality of care in gout: from measurement to improvement. , 2007, Clinical and experimental rheumatology.

[15]  J. Hodges,et al.  Quality of care for gout in the US needs improvement. , 2007, Arthritis and rheumatism.

[16]  E. Pascual,et al.  Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout , 2007, Annals of the rheumatic diseases.

[17]  Song-min Huang,et al.  Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.

[18]  Xuejun Zeng,et al.  The management of gout at an academic healthcare center in Beijing: a physician survey. , 2006, The Journal of rheumatology.

[19]  P Netter,et al.  EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT) , 2006, Annals of the rheumatic diseases.

[20]  P Netter,et al.  EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT) , 2006, Annals of the rheumatic diseases.

[21]  F. Martinon,et al.  Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.

[22]  F. Perez-Ruiz,et al.  Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. , 2002, Arthritis and rheumatism.

[23]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  D. Mccarty,et al.  Preliminary criteria for the classification of the acute arthritis of primary gout. , 1977, Arthritis and rheumatism.

[25]  J. Stockman,et al.  Febuxostat Compared with Allopurinol in Patients With Hyperuricemia and Gout , 2007 .

[26]  Qingwen Wang,et al.  Primary gout in Shantou: a clinical and epidemiological study. , 2003, Chinese medical journal.

[27]  Shao Ji.  Epidemiological study on hyperuricemia and gout in community of Nanjing , 2003 .

[28]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  H. Yamanaka,et al.  Optimal range of serum urate concentrations to minimize risk of gouty attacks during anti-hyperuricemic treatment. , 1998, Advances in experimental medicine and biology.